查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1197538

医学模拟市场 - 增长、趋势、COVID-19 影响和预测 (2023-2028)

Medical Simulation Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 115 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

在 2022 年至 2027 年的预测期内，医疗模拟市场预计将以 12.4% 的复合年增长率增长。

医学模拟在各医疗机构应对 COVID-19 大流行中发挥了重要作用。 大流行期间，各种医疗保健机构都部署了模拟培训，以完善规程、促进实践中的变化、确定安全漏洞并培训重新部署到不熟悉的角色的卫生工作者。 根据 2021 年 2 月号 Stimulation Healthcare 发表的题为“在 COVID-19 大流行期间实施模拟训练”的研究，模拟在应对大流行的过程中至关重要。 从备灾和危机资源管理中的应用，到解决基于系统的问题，如识别安全差距、制定感染控制策略和改进临床管理协议，模拟被认为是有效的。 因此，在大流行期间，医疗保健以越来越多的方式采用医学模拟，证明了大流行对市场增长的积极影响。

推动医疗模拟市场增长的因素包括持续的技术进步、对患者安全的日益关注以及对微创治疗的需求不断增长。

随着世界各地医疗机构的技术进步和创新，微创手术 (MIS) 多年来一直被认为是最理想的外科手术，因此持续发展。 MIS 作为传统开放手术的替代方案，在普通外科手术中具有重要作用，包括腹腔镜技术、心臟手术、妇科和骨科。

根据 2022 年 2 月在临床脊柱外科杂誌上发表的题为“微创与开放式脊柱手术患者偏好、理解和情绪的比较”的研究论文，在开放式手术和微创手术 (MIS) 之间进行选择时，最重要的是研究中患者确定的标准是长期结果、外科医生的建议和并发症的风险。 患者还认为 MIS 手术在术后疼痛、并发症风险、恢復时间、成本和麻醉需要方面优于开放手术。 大多数患者似乎更喜欢微创治疗。 患者普遍认为 MIS 手术比开放手术更受欢迎。 因此，对 MIS 不断增长的需求有望推动医疗模拟市场。

此外，根据 2022 年 7 月发表在印度临床麻醉杂誌上的一项名为“考虑模拟培训以确保沙特阿拉伯利雅得专家麻醉师的患者安全”的研究，高级麻醉医师是仍然积极参与患者护理和工作，并认为模拟可用于识别和解决作为医疗保健专业人员工作时与年龄相关的挑战。 它有助于确定不称职、发展技能并协助麻醉师规划他们未来的临床职业。 因此，随着对患者安全问题的日益关注，医生可能会将医疗模拟培训作为其职业生涯的重要组成部分，从而增加对医疗刺激产品和服务的需求。 随着标准化患者模拟器的使用，医疗模拟设备的使用在过去几年中经历了快速增长，这主要是由于技术进步和医疗保健领域的日益普及。 Metiman Simulator 已被证明是 CAE Simulator 最近开发的最先进和最逼真的模拟器之一。 因此，医疗模拟领域各种技术进步的兴起增加了其在医疗保健领域用于培训医务人员的应用，这将推动预测期内研究的市场增长。

医疗模拟市场趋势

预计在预测期内心臟手术模拟器将占据较大的市场份额

由于心血管疾病 (CVD) 在世界范围内的高发率，医院、研究中心对心臟模拟器的采用持续增加，这是由于手术和其他治疗程序的增加。. 例如，根据疾病控制和预防中心 2022 年 7 月的更新，到 2020 年，约有 2000 万 20 岁以上的美国人将患有冠状动脉疾病 (CAD)，这将导致约 382,□□820 人死亡。由于 2020 年和因此，由于心血管疾病的高患病率和高死亡率，全球对有效和先进治疗的需求正在增加，这推动了对心臟手术模拟器的需求，并且预计该领域在预测期内将有显着增长。 此外，根据 2020 年 2 月发表的文章“法国的心力衰竭 (HF)：慢性心力衰竭的管理和现实生活中心力衰竭的风险”，法国约有 100 万人受到心力衰竭的影响（ HF) 儘管有完善的治疗管理，HF 仍与大约 70,000 例死亡和超过 150,000 例住院有关。 此外，心臟模拟已成为大多数专业外科教育和培训的可行辅助手段，因此，随着 CVD 的高负担，研究部门预计将在预测期内增长。

此外，市场上的主要参与者推出了几款创新产品，进一步提高了这些心臟模拟器的采用率，使它们对用户和预算更友好，这一因素也有助于心臟手术模拟器的增长。预计支持 例如，2022 年 3 月，为医院和医护人员提供数字学习解决方案的领先提供商 MedLern 宣布了一个创新的在线復苏培训平台，该平台不需要导师监督，由协会和挪度医疗技术公司共同开发和交付。 因此，CVD 的高患病率和不断增加的患病率，加上对微创治疗的认识不断提高，预计将推动全球越来越多的医院采用心臟手术模拟器。 因此，由于上述原因，预计心臟手术模拟器部分在预测期内将有显着增长。

预计在预测期内北美将主导医疗模拟市场

在预测期内，预计北美将主导医疗模拟器市场。 需要手术的慢性病患病率上升、技术进步以及主要参与者的存在等因素预计将对该地区医疗模拟器设备的增长做出重大贡献。 例如，根据加拿大公共卫生署 2021 年 12 月的一份报告，每 100,000 名 65 岁及以上人群的缺血性心脏病粗发病率为男性 2,306.9 例，女性为 1,537 例，男性慢性阻塞性肺病发病率为 1,750.6 例。 , 1,411.4 为女性。 此外，根据 Globocan 2020 报告，北美地区的癌症发病人数估计将从 2020 年的 260 万增加到 2040 年的 350 万，因此该地区的慢性病负担很重。因此，预计在预测期内，该地区采用医疗模拟器的人数将会增加。

此外，该地区越来越多地采用微创手术，预计这将推动医疗模拟市场的增长，因为模拟有助于实际外科手术。 例如，根据 2021 年 11 月发表的一项题为“美国微创附件手术使用趋势”的研究，与开放手术相比，更多因良性原因接受卵巢切除术或卵巢囊肿切除术的女性更有可能接受微创手术手术由于较少的问题导致微创手术。 此外，该地区的主要参与者推出了多项创新产品，促进了这些令人兴奋的服务和商品的采用。 例如，2020 年 10 月，GIGXR, Inc. 推出了面向医疗和护理学校的 HoloPatient Remote 和 GIG Mobile。 因此，由于上述因素，北美地区有望在预测期内占据医疗模拟市场的很大份额。

医学模拟市场竞争者分析

市场高度分散，参与者众多。 中小玩家众多，竞争激烈。 在过去几年中，模拟技术的日益普及不断吸引新的参与者进入市场。 现有的参与者正试图通过价格、质量和技术使自己脱颖而出。 市场参与者包括 3D Systems、加拿大航空电子公司 (CAE)、Gaumard Scientific Company Inc、Kyoto Kagaku、Laerdal Medical、Limbs & Things Ltd。

其他福利。

  • Excel 格式的市场预测 (ME) 表
  • 3 个月的分析师支持

内容

第1章介绍

  • 研究假设和市场定义
  • 调查范围

第2章研究方法论

第 3 章执行摘要

第4章市场动态

  • 市场概览
  • 市场驱动因素
    • 技术进步
    • 对患者安全的担忧加剧
    • 对微创治疗的需求不断增长
  • 市场製约因素
    • 模拟器成本高
    • 筹资能力有限，尤其是在发展中国家和不发达国家
  • 波特的五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（基于价值的市场规模：百万美元）

  • 按产品/服务
    • 按产品分类
      • 介入/手术模拟器
      • 腹腔镜手术模拟器
      • 妇科手术模拟器
      • 心臟手术模拟器
      • 关节镜手术模拟器
      • 其他产品
      • 任务培训师
      • 其他产品和服务
    • 服务/软件
      • 基于网络的模拟
      • 医学模拟软件
      • 模拟训练服务
      • 其他服务和软件
  • 按技术
    • 高保真模拟器
    • 中等再现性模拟器
    • 低保真模拟器
  • 最终用户
    • 学术和研究机构
    • 医院
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东
      • 海湾合作委员会
      • 南非
      • 其他中东地区
    • 南美洲地区
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章竞争格局

  • 公司简介
    • 3D Systems
    • Canadian Aviation Electronics（CAE）
    • 3B Scientific GmbH Inc.（Cardionics Inc.）
    • Gaumard Scientific Company Inc.
    • Kyoto Kagaku Co. Ltd
    • Laerdal Medical
    • Limbs & Things Ltd
    • Medaphor
    • Mentice AB
    • Nasco
    • Operative Experience, Inc.
    • Simulab Corporation
    • Simulaids Inc.
    • VirtaMed AG

第7章 市场机会与今后动向

简介目录
Product Code: 55897

The medical simulation market is projected to register a CAGR of 12.4% during the forecast period, 2022-2027.

Medical Simulation has played a critical role in response to the COVID-19 pandemic in various medical institutions. Simulation training is deployed at various healthcare institutions throughout the pandemic to refine protocols, facilitate practice changes, uncover safety gaps, and train redeployed healthcare workers in unfamiliar roles. According to the study titled "Implementation of Simulation Training During the COVID-19 Pandemic" published in the Stimulation Healthcare February 2021, in the process of responding to the pandemic, simulation was crucial. It was thought that simulation would be a good way to deal with system-based problems like identifying safety gaps, developing infection control strategies, and improving clinical management protocols due to its applications in disaster preparedness and crisis resource management. Thus, healthcare has increasingly adopted medical simulation during the pandemic in many ways showing that the pandemic has a positive impact on market growth.

The propelling factors for the growth of the medical simulation market include continuous technological advancements, increasing concerns over patient safety, and growing demand for minimally invasive treatments.

Technological advancement and innovation in health care facilities across the world have seen Minimally invasive surgery (MIS) grow as it is viewed as the most desirable surgical procedure for years now. MIS plays an essential role in general surgery as an alternative to traditional open surgery including laparoscopic techniques, cardiac surgeries, gynecology, orthopedic, etc.

According to the research article titled "Comparison of Patient Preference, Understanding, and Sentiment for Minimally Invasive Versus Open Spine Surgery "published in Clinical Spine Surgery, February 2022, long-term outcomes, surgeon's recommendation, and complication risk were the most important criteria identified by patients when choosing between open and minimally invasive surgery (MIS). Patients also perceived MIS surgery to have advantages over open surgery in postoperative pain, complication risk, recovery time, cost, and anesthesia requirement. Most patients seem to prefer a minimally invasive approach to their treatment. Patients view MIS surgery more favorably than open surgery overall. Thus, a rise in the demand for MIS is anticipated to drive the medical simulation market.

Moreover, according to the study titled "Considering simulation training to ensure patient safety for expert anesthesiologists over the age of 60 in Saudi Arabia" published in the Indian Journal of Clinical Anaesthesia in July 2022, In Riyadh, Saudi Arabia, senior anesthesiologists are still actively involved in patient care and their duties, and they feel that simulation can help them recognize and address age-related problems in their work as medical professionals. Determining incompetence, enhancing skills, and assisting anesthesiologists in making plans for their future clinical careers. Therefore, as patient safety concerns increase, physicians may use medical simulation training as a crucial component of their careers, which will increase the demand for medical stimulation products and services. The use of medical simulation devices, along with standardized patient simulators, has gained rapid growth over the last few years, mainly due to increasing technological advancements and their adoption in the field of healthcare. The METIman simulator is found to be one of the most advanced and realistic simulators in recent times, developed by the CAE simulators. Thus, the rise in various technological advancements in the field of medical simulation is increasing the applications in healthcare to train healthcare professionals, and because of this, the growth of the market studied is expected to propel over the forecast period.

Medical Simulation Market Trends

Cardiac Surgical Simulators is Expected to Hold a Significant Market Share Over Forecast Period

Owing to the high prevalence of cardiovascular diseases (CVDs) around the world, the adoption rate of the cardiac simulator in hospitals, and research centers is continuously increasing due to the rising number of surgical and other treatment procedures. For instance, according to the July 2022 update of the Centers for Disease Control and Prevention, in 2020, about 20.1 million Americans of age 20 years and older had coronary artery disease (CAD) and it was responsible for about 382,820 deaths 2020 and hence, owing to the high prevalence and mortality due to the cardiovascular diseases, the demand for effective and advanced treatment is increasing globally, which is expected to drive the demand of the cardiac surgical simulators and segment is expected to have significant growth over the forecast period. Further, as per the article titled "Heart failure (HF) in France: chronic heart failure therapeutic management and risk of cardiac decompensation in real-life setting", published in February 2020, in France, around one million persons would be affected by heart failure (HF); there are nearly 70,000 deaths related to HF, and more than 150,000 hospitalizations despite well-defined treatment management. Moreover, cardiac simulation has emerged as a feasible adjunct to surgical education and training for most specialties, and thus, with the high burden of CVDs, the studied segment is expected to grow over the forecast period.

In addition, there have been several innovative product launches by the key players in the market which is further increasing the adoption of these cardiac simulators making them more user and budget-friendly, this factor is also expected to boost the growth of cardiac surgical simulators. For instance, in March 2022, MedLern, a leading digital learning solution for hospitals and healthcare professionals, unveiled an innovative, online resuscitation training platform that does not require instructor oversight, and this online program, HeartCodeComplete is co-developed and powered by the American Heart Association and Laerdal Medical technology. Therefore, the high and increasing prevalence of CVDs coupled with the growing awareness regarding minimally invasive treatments and the rising number of hospitals worldwide is expected to propel the adoption of the cardiac surgical simulator. Thus, due to the above-mentioned reasons, the cardiac surgical simulator segment is expected to have significant growth over the forecast period.

North America is Expected to Dominate the Medical Simulation Market Over the Forecast Period

North America is expected to dominate the market for medical simulators over the forecast period. The factors such as the growing prevalence of chronic diseases that require surgeries, technological advancements, and the presence of major players in this region is expected to be the major contributor to the growth of medical simulator devices. For instance, according to a report published by the Public Health Agency of Canada in December 2021, the crude incidence rate per 100,000 persons aged 65 years and more for ischemic heart disease was 2,306.9 in men and 1,537 for women and chronic obstructive pulmonary disease was 1,750.6 in men and 1,411.4 in women. In addition, according to the Globocan 2020 report, the estimated cancer prevalence in Northern America region is expected to increase from 2.6 million cases in 2020 to 3.5 million cases by 2040 and hence, owing to the high burden of chronic diseases in the region, the adoption of medical simulators is expected to increase in the region over the forecast period.

Further, the growing adoption of minimally invasive surgeries in the region is expected to boost growth in the medical simulation market as simulation helps in getting hands-on for real surgical procedures. For instance, according to the research study published in November 2021, titled "Trends in the Use of Minimally Invasive Adnexal Surgery in the United States", most women who undergo oophorectomy and ovarian cystectomy for benign causes receive minimally invasive surgery as fewer problems are linked to minimally invasive surgery than laparotomy. In addition, the major players in this region have launched several innovative products, which is boosting the adoption of these stimulating services and goods. For Instance, in October 2020, -GIGXR, Inc., a provider of the medical simulator immersive learning System for instructor-led teaching and training, launched the HoloPatient Remote and GIG Mobile for medical and nursing schools. Therefore, due to the aforementioned factors, the north American region is expected to hold a significant share in the medical simulation market over the forecast period.

Medical Simulation Market Competitor Analysis

The market is highly fragmented with many players. With many small and medium players, the competition is high. The market has been experiencing the entry of new players over the last few years, owing to the rising popularity of simulation technology. The existing players are differentiating on the basis of price, quality, and technology. some of the market players are 3D Systems, Canadian Aviation Electronics (CAE), Gaumard Scientific Company Inc., Kyoto Kagaku Co. Ltd, Laerdal Medical, Limbs & Things Ltd etc.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Technological Advancements
    • 4.2.2 Increasing Concerns over Patient Safety
    • 4.2.3 Increasing Demand for Minimally Invasive Treatments
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Simulators
    • 4.3.2 Limited Availability of Funds, Especially in the Developing and Underdeveloped Countries
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Products and Services
    • 5.1.1 Products
      • 5.1.1.1 Interventional/Surgical Simulators
      • 5.1.1.1.1 Laparoscopic Surgical Simulators
      • 5.1.1.1.2 Gynecology Surgical Simulators
      • 5.1.1.1.3 Cardiac Surgical Simulators
      • 5.1.1.1.4 Arthroscopic Surgical Simulators
      • 5.1.1.1.5 Other Products
      • 5.1.1.2 Task Trainers
      • 5.1.1.3 Other Products and Services
    • 5.1.2 Services and Software
      • 5.1.2.1 Web-based Simulation
      • 5.1.2.2 Medical Simulation Software
      • 5.1.2.3 Simulation Training Services
      • 5.1.2.4 Other Services and Software
  • 5.2 By Technology
    • 5.2.1 High-fidelity Simulators
    • 5.2.2 Medium-fidelity Simulators
    • 5.2.3 Low-fidelity Simulators
  • 5.3 By End User
    • 5.3.1 Academic and Research Institutes
    • 5.3.2 Hospitals
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 3D Systems
    • 6.1.2 Canadian Aviation Electronics (CAE)
    • 6.1.3 3B Scientific GmbH Inc. (Cardionics Inc.)
    • 6.1.4 Gaumard Scientific Company Inc.
    • 6.1.5 Kyoto Kagaku Co. Ltd
    • 6.1.6 Laerdal Medical
    • 6.1.7 Limbs & Things Ltd
    • 6.1.8 Medaphor
    • 6.1.9 Mentice AB
    • 6.1.10 Nasco
    • 6.1.11 Operative Experience, Inc.
    • 6.1.12 Simulab Corporation
    • 6.1.13 Simulaids Inc.
    • 6.1.14 VirtaMed AG

7 MARKET OPPORTUNITIES AND FUTURE TRENDS